Elevation Oncology Net Income

Elevation Oncology (ELEV) currently reports a net income of $-48M as of March 2025. That compares with $-39M in the prior-year period — down 21.9% year over year. That is below the Healthcare sector average of $17B. Use the charts on this page to explore Elevation Oncology's net income history and peer comparisons.

Elevation Oncology's net income decreased from $-39M to $-48M — a 21.9% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Elevation Oncology's net income of $-48M is lower than the Healthcare sector average of $17B. That is roughly 100.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Elevation Oncology reported $-48M in net income as of March 2025. That compares with $-39M in the prior-year period — down 21.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-48M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $17B. From there, open related valuation or income-statement pages for Elevation Oncology, and consider following ELEV for alerts when major investors trade the stock.